PURPOSE: To assess the value of an abnormal fluorescein dye disappearance test (FDDT), lacrimal syringing, and Jones test for patients with epiphora who are clinically patent to syringing.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback